Noriyuki Kasahara
Affiliations: | University of Southern California, Los Angeles, CA, United States |
Area:
Molecular Biology, Genetics, Microbiology Biology, OncologyGoogle:
"Noriyuki Kasahara"Children
Sign in to add trainee| Christopher R. Logg | grad student | 2002 | USC |
| Harris S. Soifer | grad student | 2002 | USC |
| Chien-Kuo Tai | grad student | 2002 | USC |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Niwa H, Nakamura T, Kushiya H, et al. (2024) Therapeutic activity of retroviral replicating vector-mediated gene therapy in combination with anti-PD-1 antibody in a murine pancreatic cancer model. Cancer Gene Therapy |
| Sonoda-Fukuda E, Takeuchi Y, Ogawa N, et al. (2024) Targeted Suicide Gene Therapy with Retroviral Replicating Vectors for Experimental Canine Cancers. International Journal of Molecular Sciences. 25 |
| Isoda L, Sonoda-Fukuda E, Fujino H, et al. (2023) Therapeutic Efficacy of Prodrug Activator Gene Therapy Using Retroviral Replicating Vectors for Human Ovarian Cancer. Anticancer Research. 43: 5311-5317 |
| Fujino H, Sonoda-Fukuda E, Isoda L, et al. (2023) Retroviral Replicating Vectors Mediated Prodrug Activator Gene Therapy in a Gastric Cancer Model. International Journal of Molecular Sciences. 24 |
| Kushiya H, Hiraoka K, Suzuki T, et al. (2022) Retroviral Replicating Vector Toca 511 () for Prodrug Activator Gene Therapy of Lung Cancer. Cancers. 14 |
| Collins SA, Shah AH, Ostertag D, et al. (2021) Clinical development of retroviral replicating vector Toca 511 for gene therapy of cancer. Expert Opinion On Biological Therapy |
| Montoya ML, Kasahara N, Okada H. (2020) Introduction to immunotherapy for brain tumor patients: challenges and future perspectives. Neuro-Oncology Practice. 7: 465-476 |
| Chen SH, Sun JM, Chen BM, et al. (2020) Efficient Prodrug Activator Gene Therapy by Retroviral Replicating Vectors Prolongs Survival in an Immune-Competent Intracerebral Glioma Model. International Journal of Molecular Sciences. 21 |
| Inagaki A, Takahashi M, Kamijima S, et al. (2019) Stem-24. Therapeutic Approach Of Stem Cell Carrying Retroviral Replicating Vectors In Human Glioma Model Neuro-Oncology. 21 |
| Collins S, Kamath P, Matsuura S, et al. (2019) Therapeutic efficacy of vocimagene amiretrorepvec (Toca 511) prodrug activator gene therapy in peritoneal carcinomatosis models of ovarian cancer Gynecologic Oncology. 154: e29-e30 |